Form D — Argonaute RNA Ltd

0002157150-26-000001 · filed Sep 24, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $1,800,000
Reported amount sold: $1,800,000
Minimum investment: $10,000
Investors: 27
Sales commission: $0
Finders' fees: $0

Issuer

Name: Argonaute RNA Ltd
CIK: 2157150
Entity: Corporation
Jurisdiction: UNITED KINGDOM
Year incorporated: —
Address: CARDIFF BUSINESS TECHNOLOGY CENTRE
CARDIFF, X0 CF24 4AY
Phone: 00441179742562

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Anthony Michael Parker · Executive Officer

Portishead, X0 Find on LinkedIn ↗
Michael Mohamed Tarik Khan · Executive Officer

Newbold on Stour, X0 Find on LinkedIn ↗
Richard Michael Tompkins · Director

Congresbury, X0 Find on LinkedIn ↗
Johnathan Vincent Matlock · Director

Clophill, X0 Find on LinkedIn ↗
David William Dawson Ball · Director

Shamley Green, X0 Find on LinkedIn ↗
Alexander Michael Fink · Director

London, X0 Find on LinkedIn ↗
Ross Thomas Burn · Director

Bristol, X0 Find on LinkedIn ↗
Nabil Hussain Muhiddin Al-Chalaby · Director

Poole, X0 Find on LinkedIn ↗
Nigel Keith Davis · Director

Kenilworth, X0 Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗